Prometrium Cost in Tennessee (2026): Cash Prices, Insurance, and Savings Options

How Much Does Prometrium Cost in Tennessee in 2026?
At a glance
- Brand Prometrium list price / $180 per month (Solvay/AbbVie)
- Average TN retail cash price / $45 per month in 2026
- Compounded micronized progesterone / $25 per month via 503A pharmacies
- Tennessee Medicaid coverage / Not covered for HRT endometrial protection
- Telehealth prescribing / Legal and available statewide in Tennessee
- Standard dosing / 200 mg oral capsule once daily at bedtime
- Discount programs / AbbVie savings card, GoodRx, RxAssist
- Compounding legality / Permitted through licensed 503A pharmacies
- Common indication / Endometrial protection during estrogen therapy
- FDA status / Prescription only
Tennessee Retail Pricing Breakdown
The gap between list price and what patients actually pay in Tennessee is substantial. AbbVie's wholesale acquisition cost sits at $180 per month for brand-name Prometrium (micronized progesterone 200 mg capsules, 30-count). Retail pharmacies in Tennessee, however, price the generic far lower.
Across major Tennessee chains (CVS, Walgreens, Kroger Pharmacy), the average cash price for generic micronized progesterone 200 mg #30 in 2026 is approximately $45 per month without insurance or coupons. Pricing varies by metro area. Nashville and Memphis pharmacies tend to cluster around $42 to $48, while rural East Tennessee pharmacies may charge $50 to $55 due to lower volume purchasing.
The PEPI trial (Postmenopausal Estrogen/Progestin Interventions, N=875) established micronized progesterone as effective endometrial protection during estrogen therapy, demonstrating equivalent prevention of endometrial hyperplasia compared to medroxyprogesterone acetate with a more favorable lipid profile 1. This evidence base underpins the current standard of prescribing 200 mg at bedtime for 12 days per calendar month (cyclic) or 100 mg nightly (continuous) alongside estrogen.
For patients paying out of pocket in Tennessee, the practical choice comes down to three tiers: brand Prometrium at $180, generic micronized progesterone at $45, or compounded micronized progesterone at $25.
Tennessee Medicaid: Coverage Gaps for HRT
TennCare (Tennessee's Medicaid program) does not cover Prometrium or generic micronized progesterone when prescribed for endometrial protection as part of hormone replacement therapy. The drug appears on TennCare's formulary only for specific indications related to type 2 diabetes management, not menopausal HRT.
This creates a real access barrier. According to the Endocrine Society's 2022 clinical practice guideline on menopause management, progesterone co-administration with estrogen is mandatory for endometrial protection in women with an intact uterus. The guideline specifically names micronized progesterone as the preferred progestogen based on cardiovascular and breast safety data.
Tennessee women on TennCare who need HRT must pay cash for their progesterone component or seek compounded alternatives. Approximately 340,000 Tennessee women ages 45 to 64 are enrolled in TennCare, and a meaningful subset require menopausal HRT. The coverage exclusion forces these patients into the retail cash market or toward 503A compounding pharmacies.
Prior authorization requests for off-formulary use of micronized progesterone under TennCare have a low approval rate when the indication is listed as "endometrial protection" or "menopause." Providers who have successfully obtained coverage have documented the indication as secondary amenorrhea (an FDA-approved indication per the Prometrium prescribing information), though this approach requires careful clinical documentation.
Compounded Micronized Progesterone in Tennessee
Compounded micronized progesterone is legal in Tennessee through licensed 503A pharmacies. Tennessee Board of Pharmacy regulations permit patient-specific compounding under a valid prescription, following federal guidelines established by the Drug Quality and Security Act of 2013.
The cost advantage is significant: $25 per month for compounded micronized progesterone versus $45 for manufactured generic. Several Tennessee compounding pharmacies serve patients statewide with shipping, including operations in Nashville, Knoxville, and Chattanooga.
Key distinctions patients should understand:
Compounded products are not FDA-approved and do not undergo the same bioequivalence testing as manufactured generics. The FDA's guidance on compounding notes that 503A compounded medications are appropriate when a commercially available product does not meet a patient's medical needs (allergy to a dye or filler, need for a non-standard dose, or inability to swallow capsules).
For patients who tolerate standard 100 mg or 200 mg capsules and have no filler sensitivities, manufactured generic micronized progesterone at $45 per month offers the assurance of FDA oversight at a modest premium over compounded. For patients who need custom dosing (e.g., 150 mg, or progesterone in a different delivery form such as vaginal suppository or topical cream), compounding fills a legitimate clinical gap.
Tennessee does not restrict telehealth prescribing of compounded progesterone. A provider licensed in Tennessee can prescribe to a 503A pharmacy after a telehealth consultation.
Insurance Coverage Beyond Medicaid
Commercial insurance plans in Tennessee generally cover generic micronized progesterone, though tier placement and copay amounts vary considerably.
BlueCross BlueShield of Tennessee (BCBST): Generic micronized progesterone sits on Tier 1 (preferred generic) for most BCBST plans. Typical copay: $10 to $15 for a 30-day supply. Brand Prometrium requires Tier 3 copay ($45 to $75) or prior authorization on some plans.
Cigna Tennessee plans: Generic covered at Tier 1. The Cigna Performance Drug List includes micronized progesterone without prior authorization for the 100 mg and 200 mg strengths.
UnitedHealthcare (UHC) Tennessee: Covered on most commercial plans at Tier 1. UHC Medicare Advantage plans in Tennessee also cover generic micronized progesterone, unlike TennCare.
Humana (strong Tennessee presence): Generic covered at Tier 1. Brand requires step therapy showing generic trial first.
Dr. JoAnn Pinkerton, former Executive Director of The North American Menopause Society, has stated: "Micronized progesterone remains the preferred progestogen for most women on hormone therapy based on its safety profile in observational data and the PEPI randomized trial" 2. This clinical preference drives formulary inclusion on most commercial plans.
For patients between insurance plans or on high-deductible health plans (HDHPs), the cash price of $45 often beats the deductible-phase "negotiated rate" that some PBMs charge. Checking both the pharmacy's cash price and the insurance price before filling is a practical step Tennessee patients should take at every refill.
Discount Programs and Savings Cards
Several mechanisms can reduce out-of-pocket cost below the $45 Tennessee average:
AbbVie Savings Card: AbbVie (which acquired the Prometrium brand through its Allergan acquisition) offers a manufacturer savings card for brand-name Prometrium. The card covers up to $75 off per fill for commercially insured patients. Patients with commercial insurance and a high copay for brand Prometrium can reduce their cost to as low as $0 to $25 per fill. The card is not valid for patients on government insurance (Medicare, Medicaid, Tricare, VA).
The card works at any Tennessee retail pharmacy that accepts manufacturer copay cards. Enrollment is available online and the card is reusable for 12 monthly fills per calendar year.
GoodRx and Similar Discount Platforms: GoodRx, SingleCare, and RxSaver show Tennessee-specific pricing for generic micronized progesterone. Current GoodRx pricing (May 2026) shows generic 200 mg #30 as low as $12 to $18 at Costco Pharmacy and $22 to $28 at Kroger in Nashville. These prices beat the $45 average significantly.
Mark Cuban Cost Plus Drugs: Cost Plus Drugs sells generic micronized progesterone 200 mg #30 for $5.40 plus a $5 pharmacy fee and $5 shipping, totaling approximately $15.40 delivered to any Tennessee address. This represents the lowest price point available to Tennessee residents, though shipping time (5 to 7 business days) requires planning ahead.
RxAssist and Patient Assistance Programs: For uninsured patients who do not qualify for TennCare, AbbVie's patient assistance program provides brand Prometrium at no cost to qualifying patients (household income below 200% of the federal poverty level). Application requires provider involvement and income verification.
Telehealth Access in Tennessee
Tennessee permits telehealth prescribing of Prometrium and generic micronized progesterone without geographic restrictions within the state. The Tennessee Board of Medical Examiners requires that the prescribing provider hold an active Tennessee medical license (or participate in an interstate compact that covers Tennessee).
Since 2023, Tennessee has maintained its pandemic-era telehealth flexibilities as permanent law. A provider can establish a patient-provider relationship via synchronous video visit and prescribe micronized progesterone at that initial encounter. No in-person visit is required.
This matters for Tennessee's rural population. Approximately 28% of Tennessee residents live in rural areas where access to a menopause specialist or reproductive endocrinologist may require driving 60 or more miles. Telehealth platforms that specialize in HRT (including HealthRX) can prescribe micronized progesterone to patients anywhere in Tennessee and send the prescription to any licensed pharmacy, whether retail, mail-order, or 503A compounding.
The prescription itself is standard: micronized progesterone 200 mg capsule, take one capsule by mouth at bedtime, quantity 30, with refills. Tennessee pharmacies fill telehealth prescriptions identically to in-person prescriptions. There is no pharmacy-level distinction or additional verification requirement for telehealth-originated controlled or non-controlled prescriptions in Tennessee.
Prometrium vs. Synthetic Progestins: Why Cost Comparisons Matter
Patients sometimes ask why they should pay $45 for micronized progesterone when medroxyprogesterone acetate (Provera) costs $4 to $8 at Tennessee pharmacies. The answer lies in clinical evidence.
The Women's Health Initiative (WHI) demonstrated increased breast cancer risk with the estrogen-plus-medroxyprogesterone arm (HR 1.26 to 95% CI 1.00 to 1.59) 3. The French E3N cohort study (N=80,377) subsequently showed that micronized progesterone combined with estrogen did not increase breast cancer risk over a mean follow-up of 8.1 years (RR 1.00 to 95% CI 0.83 to 1.22) 4.
The Endocrine Society's 2022 guideline states: "We suggest micronized progesterone or dydrogesterone rather than synthetic progestins for endometrial protection based on a potentially lower breast cancer risk" 5. This conditional recommendation, while not absolute, reflects the weight of observational evidence favoring micronized progesterone's safety profile.
The $37 to $41 monthly premium over medroxyprogesterone acetate buys a meaningfully different risk profile for long-term use. For women planning 5 or more years of HRT (common in early menopause or surgical menopause), the cumulative risk difference becomes clinically relevant.
How to Get the Lowest Price in Tennessee
A decision pathway for Tennessee residents seeking micronized progesterone:
If you have commercial insurance: Check your formulary. Generic micronized progesterone is likely Tier 1 with a $10 to $15 copay. If brand-only is covered, use the AbbVie savings card to reduce your copay.
If you are uninsured or on a high-deductible plan: Use GoodRx or SingleCare at a Tennessee Costco or Kroger ($12 to $28). Or order from Mark Cuban Cost Plus Drugs ($15.40 delivered).
If you are on TennCare: Pay cash at a pharmacy using a discount card ($12 to $28 with GoodRx), use a 503A compounding pharmacy ($25), or order from Cost Plus Drugs ($15.40). Ask your provider about documenting the indication as secondary amenorrhea if clinically appropriate for a prior authorization attempt.
If you need a non-standard dose or form: Use a licensed Tennessee 503A compounding pharmacy ($25 per month for standard preparations; custom forms may cost $30 to $50).
If you qualify for patient assistance: Apply through AbbVie's program for free brand Prometrium (income <200% FPL, no government insurance).
The lowest verified price available to any Tennessee resident as of May 2026 is $15.40 via Cost Plus Drugs for generic micronized progesterone 200 mg #30, delivered by mail.
Frequently asked questions
›How much does Prometrium cost in Tennessee?
›Does Tennessee Medicaid cover Prometrium?
›Is compounded micronized progesterone legal in Tennessee?
›Can I get Prometrium via telehealth in Tennessee?
›Which insurance plans cover Prometrium in Tennessee?
›What's the cheapest way to get Prometrium in Tennessee?
›Are there Tennessee Prometrium discount programs?
›How does the AbbVie savings card work in Tennessee?
›What dose of Prometrium do most Tennessee providers prescribe?
›Can I switch from brand Prometrium to generic in Tennessee?
›Does Prometrium require prior authorization in Tennessee?
›Is Prometrium covered under Tennessee state employee insurance?
References
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
- Prometrium (progesterone, USP) Capsules 100 mg, 200 mg. FDA Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/019781s013lbl.pdf
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333. https://pubmed.ncbi.nlm.nih.gov/12117397/
- Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/18460166/
- Pinkerton JV, Aguirre FS, Blake J, et al. The 2022 hormone therapy position statement of The North American Menopause Society. J Clin Endocrinol Metab. 2022;107(9):2569-2595. https://academic.oup.com/jcem/article/107/9/2569/6625230
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers